Huang M - Search Results

1

Immediate breast reconstruction with omental flap for luminal breast cancer patients: Ten clinical case reports.

Li N, Zheng Z, Li J, Fan J, Wang T, Zhang J, Wang H, Chen J, Lv Y, Yi J, Huang M, Ling R. Li N, et al. Among authors: huang m. Medicine (Baltimore). 2017 Aug;96(33):e7797. doi: 10.1097/MD.0000000000007797. Medicine (Baltimore). 2017. PMID: 28816969 Free PMC article.

2

Establishment and Clinical Application of an Electronic Database for Breast Cancer in China.

Lv YG, Huang ML, Xiao JJ, Ling R. Lv YG, et al. Asian Pac J Cancer Prev. 2016;17(2):639-41. doi: 10.7314/apjcp.2016.17.2.639. Asian Pac J Cancer Prev. 2016. PMID: 26925656 Free article.

3

Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.

Wu J, Li WZ, Huang ML, Wei HL, Wang T, Fan J, Li NL, Ling R. Wu J, et al. Biochem Biophys Res Commun. 2017 Jan 29;483(1):10-16. doi: 10.1016/j.bbrc.2017.01.023. Epub 2017 Jan 7. Biochem Biophys Res Commun. 2017. PMID: 28069384

4

A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01).

Chen J, Yao Q, Huang M, Wang B, Zhang J, Wang T, Ming Y, Zhou X, Jia Q, Huan Y, Wang J, Wang L. Chen J, et al. Among authors: huang m. Int J Cancer. 2018 May 15;142(10):2130-2138. doi: 10.1002/ijc.31217. Epub 2017 Dec 23. Int J Cancer. 2018. PMID: 29238974 Clinical Trial.

5

Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: A population-based retrospective study of 2490 patients.

Huang M, Yan C, Wei H, Lv Y, Ling R. Huang M, et al. Thorac Cancer. 2018 Nov;9(11):1453-1460. doi: 10.1111/1759-7714.12858. Epub 2018 Sep 12. Thorac Cancer. 2018. PMID: 30209893 Free PMC article.

6

Intraoperative rapid aspiration cytological method for parathyroid glands identification and protection.

Wei H, Huang M, Fan J, Wang T, Ling R. Wei H, et al. Among authors: huang m. Endocr J. 2019 Feb 28;66(2):135-141. doi: 10.1507/endocrj.EJ18-0363. Epub 2018 Dec 5. Endocr J. 2019. PMID: 30518736 Free article.

7

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma.

Yan C, Huang M, Li X, Wang T, Ling R. Yan C, et al. Among authors: huang m. Endocr Connect. 2019 Jul;8(7):988-996. doi: 10.1530/EC-19-0246. Endocr Connect. 2019. PMID: 31252408 Free PMC article.

8

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.

Huang M, Yan C, Xiao J, Wang T, Ling R. Huang M, et al. Diagn Pathol. 2019 Jul 12;14(1):74. doi: 10.1186/s13000-019-0849-6. Diagn Pathol. 2019. PMID: 31300059 Free PMC article.

9

Small molecule HDAC inhibitors: Promising agents for breast cancer treatment.

Huang M, Zhang J, Yan C, Li X, Zhang J, Ling R. Huang M, et al. Bioorg Chem. 2019 Oct;91:103184. doi: 10.1016/j.bioorg.2019.103184. Epub 2019 Aug 5. Bioorg Chem. 2019. PMID: 31408831 Review.

10

Quadruple negative breast cancer.

Huang M, Wu J, Ling R, Li N. Huang M, et al. Breast Cancer. 2020 Jul;27(4):527-533. doi: 10.1007/s12282-020-01047-6. Epub 2020 Jan 14. Breast Cancer. 2020. PMID: 31939077 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,659 results

Search Page

Filters